| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3198247 | Journal of Allergy and Clinical Immunology | 2013 | 12 Pages |
Abstract
Mepolizumab was well tolerated and effective as a long-term corticosteroid-sparing agent in PDGFRA-negative HES.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Florence E. MD, Jean-Emmanuel MD, Gerald J. MD, Lawrence B. MD, Anish D. MD, Lanny J. MD, Judah A. MD, Johannes MD, Marc E. MD, PhD, Javed MD, Ann E. BSN, Stephen A. MSc, Deborah N. MSN, Hector G. MD, ScD, Amy D. MD,